More pharmacies to carry Crixivan. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply. NLM AIDSLINE Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


More pharmacies to carry Crixivan. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.

GMHC Treat Issues. 1997 Mar;11(3):8-9. Unique Identifier : AIDSLINE AIDS/97702566


Abstract: Access to indinavir (Crixivan) has been severely limited by production problems since it entered the market in March of 1996, and access has only been through the mail-order Stadtlander's Pharmacy. Merck is finally expanding its distribution program to include other pharmacies, but people must still enroll in a cumbersome distribution program to receive the drug. It is unlikely that anyone will be able to walk into a pharmacy and get the drug. Merck does not foresee going into normal distribution soon. Although production has increased, quantities are limited. The drug has been approved in 49 countries and supplies are closely monitored.
Keywords: HIV Protease Inhibitors/*SUPPLY & DISTRIBUTION Human Indinavir/*SUPPLY & DISTRIBUTION Pharmacies United States NEWSLETTER ARTICLEKWDhivproteaseinhibitors/KWDsupply&distributionhumanindinavir/KWDsupply&distributionpharmaciesunitedstatesnewsletterarticle
970830
M9781185

Copyright © 1997 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .